Susquehanna Fundamental Investments’s Integra LifeSciences IART Stock Holding History

Susquehanna Fundamental Investments’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,175	Closed	-$1.45M	–	758
2023 Q1	$1.45M	Sell	25,175 -3,019	-11%	-$170K	0.03%	445
2022 Q4	$1.58M	Sell	28,194 -50,786	-64%	-$2.58M	0.03%	549
2022 Q3	$3.35M	Buy	+78,980	New	+$4.05M	0.06%	437
2022 Q1	$1.7M	Buy	+26,379	New	+$1.74M	0.03%	646
2021 Q4	–	Sell	-36,919	Closed	-$2.53M	–	1588
2021 Q3	$2.53M	Sell	36,919 -4,700	-11%	-$332K	0.05%	528
2021 Q2	$2.84M	Buy	41,619 +1,450	+4%	+$103K	0.05%	475
2021 Q1	$2.77M	Hold	40,169	–	–	0.05%	526
2020 Q4	$2.61M	Buy	40,169 +28,569	+246%	+$1.54M	0.05%	537
2020 Q3	$548K	Buy	11,600 +4,400	+61%	+$209K	0.02%	844
2020 Q2	$338K	Buy	+7,200	New	+$354K	0.02%	715

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna Fundamental Investments's IART Position: Q2 2023 in Review

Susquehanna Fundamental Investments sold out of Integra LifeSciences (IART) in Q2 2023, closing a stake of 25,175 shares — an estimated $1.45M sold.

Susquehanna Fundamental Investments first reported a position in IART in Q2 2020 and held it in 10 quarters. The position peaked at $3.35M in Q3 2022. 283 funds tracked by Wall St. Rank hold IART as of Q2 2023.

Susquehanna Fundamental Investments reported no remaining Integra LifeSciences position as of Q2 2023 after selling out during the quarter.
Susquehanna Fundamental Investments sold 25,175 Integra LifeSciences shares in Q2 2023, an estimated $1.45M.
Susquehanna Fundamental Investments first reported a position in Integra LifeSciences in Q2 2020 and held it in 10 quarters.
Susquehanna Fundamental Investments's Integra LifeSciences position peaked at $3.35M in Q3 2022.
283 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2023.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2023, filed 11 Aug 2023.